Kern M J, Talley J D, Deligonul U, Serota H, Aguirre F, Gudipati C, Ring M, Joseph A, Yussman Z A, Kulick D
Cardiology Division, St. Louis University Hospital, MO 63110.
Cathet Cardiovasc Diagn. 1991 Jan;22(1):60-3. doi: 10.1002/ccd.1810220115.
With the reduction in profile of balloon dilation catheters, until recently, it has been the internal dimensions and performance of the guiding catheter that has mandated the use of 7, 8 or 9 French (F) systems for the performance of percutaneous transluminal coronary angioplasty (PTCA). A new 5F catheter design (Sherwood Medical Co., St. Louis, MO) provided a large inner lumen (0.4") permitting use of 0.20-0.22" fixed-wire PTCA balloon catheters with good coronary visualization. Potential advantages include reduced coronary artery ostial trauma and catheter induced damping and enhanced patient comfort. We report our initial experience in 14 patients undergoing PTCA with a 5 and 6F guide/fixed-wire system. Mean age was 63 +/- 10 (43-78 years). PTCA indications: Cardiogenic shock (1), post-myocardial infarction angina pectoris (2), grade III angina (5) and unstable angina pectoris (6). Vessel attempted: Left anterior descending (3), circumflex (4), obtuse marginal (2), diagonal (1), right coronary artery (3), and internal thoracic artery (1). Twelve patients had femoral approach; two brachial approach. The USCI Probe (USCI Division, Billerica, MA) was used in 8 lesions and SCIMED ACE (SCIMED Life Systems, Maplegrove, MN) catheter in 7 lesions. Successful 5 or 6F guide/fixed-wire dilations reduced the stenosis (77 +/- 14 to 37 +/- 30%) and were successfully performed in 79% (11/14). One 5F patient required 8F guiding catheter and was dilated with 2.0 fixed-wire balloon. A second failed 5F PTCA could not be dilated with any larger conventional system. A third total occlusion could not be crossed with a guidewire or fixed wire balloon. No patient had a complication.(ABSTRACT TRUNCATED AT 250 WORDS)
随着球囊扩张导管外形尺寸的减小,直到最近,经皮腔内冠状动脉成形术(PTCA)操作中,一直是引导导管的内部尺寸和性能决定了要使用7、8或9法式(F)系统。一种新型的5F导管设计(Sherwood Medical Co., 圣路易斯,密苏里州)提供了较大的内腔(0.4英寸),允许使用0.20 - 0.22英寸的固定导丝PTCA球囊导管,且冠状动脉显影良好。潜在优势包括减少冠状动脉开口处创伤、导管引起的阻尼,并提高患者舒适度。我们报告了14例使用5F和6F引导/固定导丝系统进行PTCA患者的初步经验。平均年龄为63±10岁(43 - 78岁)。PTCA适应证:心源性休克(1例)、心肌梗死后心绞痛(2例)、III级心绞痛(5例)和不稳定型心绞痛(6例)。尝试治疗的血管:左前降支(3例)、回旋支(4例)、钝缘支(2例)、对角支(1例)、右冠状动脉(3例)和胸廓内动脉(1例)。12例患者采用股动脉入路;2例采用肱动脉入路。8处病变使用了USCI Probe(USCI Division, 比勒里卡,马萨诸塞州),7处病变使用了SCIMED ACE(SCIMED Life Systems, 马普格罗夫,明尼苏达州)导管。成功的5F或6F引导/固定导丝扩张使狭窄程度降低(从77±14%降至37±30%),成功率为79%(11/14)。1例5F患者需要8F引导导管,并使用2.0固定导丝球囊进行扩张。第二例5F PTCA失败,无法用任何更大的传统系统进行扩张。第三例完全闭塞病变无法通过导丝或固定导丝球囊通过。无患者出现并发症。(摘要截断于250字)